Publication | Open Access
Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK
35
Citations
48
References
2021
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1